Key Highlights

● The board approved issuing 1,980,000 Class A and 500,000 Class C shares to six directors and officers.

● The grants form part of fiscal year 2027 remuneration packages rather than a one-time bonus.

● The filing does not name the six recipients or break down how the shares were allocated among them.

● The new shares carry resale restrictions set out in a deed of undertaking not detailed in the filing.

Mobile-health Network Solutions (NASDAQ:MNDR), a Singapore-based foreign private issuer, disclosed in a Form 6-K filed September 25, 2026 that its board approved issuing 1,980,000 Class A ordinary shares and 500,000 Class C ordinary shares to six directors and officers on September 22, 2026 as part of their remuneration for fiscal year 2027.

What the Filing Says

The 6-K states the board resolution was passed on September 22, 2026, authorizing the share grants to six unnamed directors and officers. The filing describes the awards as being made "as part of their remuneration packages in fiscal year 2027," tying the issuance directly to compensation for the year ahead rather than to a one-time Bonus or a specific past achievement. The document was signed by Siaw Tung Yeng, who holds the dual role of Co-Chief Executive Officer and Chairman.

Notably, the filing does not name the six recipients individually, nor does it break down how many of the 1,980,000 Class A shares and 500,000 Class C shares went to each person. It also does not state the value assigned to the shares for compensation purposes or disclose a vesting schedule tied to continued service.

The Transfer Restriction

One detail the filing does spell out is that the newly Issued Shares carry limits on resale: they are "subject to share transfer restrictions as set out in a deed of undertaking." That kind of restriction is a common feature of executive compensation grants, intended to discourage recipients from immediately selling shares they receive as pay, though the 6-K does not specify the length of the restriction period or the exact terms of the underlying deed.

Class Structure and What It Means

Mobile-health Network Solutions has at least two classes of ordinary shares outstanding, Class A and Class C, based on this filing's description of the new issuance. Companies with multiple share classes often use that structure to preserve concentrated voting control among insiders or founders even as the overall share count grows through compensation grants or financings; the 6-K itself does not detail the specific voting rights attached to each class. Because the Class C award is smaller in number than the Class A award, it may be reserved for a narrower subset of the six recipients, though the filing does not break the allocation down that way.

Company Background

The filing identifies Mobile-health Network Solutions as a foreign private issuer headquartered at 2 Venture Drive, #07-08 Vision Exchange, Singapore, with SEC file number 001-41990. As a foreign private issuer, the company reports material events to U.S. investors through Form 6-K rather than the Form 8-K used by domestic filers, and it can rely on a more flexible set of disclosure and governance rules than a comparable U.S.-incorporated company. Beyond identifying its Singapore address and filer status, this particular 6-K does not include a broader description of the company's mobile-health products or Business operations. Its shares trade on Nasdaq under the ticker MNDR, and the filing was executed on the company's behalf by its Co-Chief Executive Officer and Chairman.

Details Still Missing From Investors' View

Because the filing does not identify the six recipients or the value of the awards, watch for the company's future Annual Report or proxy-style disclosure, which is typically where a foreign private issuer would name executive officers and detail their individual compensation, including Equity awards like this one. Investors should also watch for any 6-K describing the specific terms of the deed of undertaking that restricts resale of the new shares, since that document was referenced but not filed alongside this report. Also watch whether the company discloses a compensation value assigned to the awards when it reports fiscal 2027 results.